Early experience with simulect (basiliximab) induction in living donor renal allografting in India.
Siwach
V
V
Renal Transplant Unit, R.K.C.T. Hospital, Amritsar, India.
Dhanda
R
R
Aggarwal
B
B
Singh
B
B
Jain
P K
PK
Sarin
P K
PK
D000328:Adult; D000368:Aged; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D001379:Azathioprine / Q000627:therapeutic use; D000077552:Basiliximab; D016572:Cyclosporine / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000453:epidemiology; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007676:Kidney Failure, Chronic / Q000601:surgery; D016030:Kidney Transplantation / Q000276:immunology*; D019520:Living Donors; D008875:Middle Aged; D011239:Prednisolone / Q000627:therapeutic use; D011993:Recombinant Fusion Proteins; D013997:Time Factors; D014184:Transplantation, Homologous / Q000276:immunology
D000911:Antibodies, Monoclonal; D007166:Immunosuppressive Agents; D011993:Recombinant Fusion Proteins; D016572:Cyclosporine; D000077552:Basiliximab; D011239:Prednisolone; D001379:Azathioprine